Insiders · Profile

Jenkins John Kenneth

Director at Corbus Pharmaceuticals. Filing since 15 Mar 2019. CIK 0001742557

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jun 2026
Director
Sold on a plan
4,800
$37.99K
55.6%
30 May 2025
Director
Sold on a plan
2,783
$20.47K
98.8%
15 Mar 2019
Director
Bought
1,000
$6.98K
opened
3 decisions on file.